We'll know the monetisation potential of nearcast if/when they land a deal or two. Might be time to sell up to APO and we can all go our separate ways to the next opportunity.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025